Clenbuterol: Compound Profile
Clenbuterol is a selective beta-2 adrenergic receptor agonist originally developed as a bronchodilator compound. This pharmaceutical-grade formulation from Hilma Biocare provides researchers with standardised 40mcg tablets for investigating thermogenic pathways, metabolic rate modulation, and cellular energy expenditure mechanisms. As a sympathomimetic compound, clenbuterol demonstrates potent effects on lipolysis and mitochondrial bioenergetics in preclinical models. Research laboratories studying metabolic dysfunction, thermogenesis, and energy balance utilise this compound to examine beta-adrenergic signalling cascades. The compound’s oral bioavailability and extended half-life make it valuable for sustained metabolic research protocols examining cellular energy utilisation patterns.
Laboratory Applications
Research institutions investigate clenbuterol for its effects on brown adipose tissue activation, uncoupling protein expression, and thermogenic gene transcription. Studies examine its role in modulating lipid oxidation pathways, glycogen metabolism, and insulin sensitivity markers in cellular models. Comparative metabolism research utilises this compound alongside other beta-agonists to evaluate tissue-specific receptor binding affinities. Researchers at Stroid UK Shop examine clenbuterol’s effects on mitochondrial respiratory chain efficiency and ATP synthesis rates. The compound serves as a reference standard in metabolic research protocols investigating sympathetic nervous system activation. Advanced studies combine clenbuterol with selective androgen receptor modulators to examine synergistic effects on body composition parameters. Comparative research includes analysis alongside metabolic peptides for comprehensive metabolic pathway mapping.
Product Specifications
| Chemical Name | 4-Amino-alpha-[(tert-butylamino)methyl]-3,5-dichlorobenzyl alcohol hydrochloride |
|---|---|
| CAS Number | 21898-19-1 |
| Molecular Formula | C₁₂H₁₈Cl₂N₂O·HCl |
| Molecular Weight | 313.65 g/mol |
| Concentration | 40mcg per tablet |
| Package Size | 50 tablets |
| Manufacturer | Hilma Biocare |
| Storage | Room temperature, dry conditions |
Research Compliance
This product is intended strictly for in-vitro laboratory research applications only. Not approved for human consumption, clinical use, or therapeutic applications. Research facilities must maintain appropriate handling protocols and documentation for all experimental procedures. Investigators should consult institutional review boards regarding proper research methodologies and safety protocols.
